Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
-
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
-
Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals (SYRS) to Raise Approximately $190 Million Through Merger with TYME Technologies (TYME) and Concurrent Private Placement
-
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
-
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Syros Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
-
Form SC 13G Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Syros Closes $90.5 Million Strategic Financing
-
Syros Pharmaceuticals (SYRS) Acquires Clinical-Stage Drug Candidate, SY-2101, for Acute Promyelocytic Leukemia from Orsenix, LLC
-
Syros Acquires Clinical-Stage Drug Candidate for Acute Promyelocytic Leukemia, Expanding Its Pipeline of Targeted Therapies for Hematologic Malignancies
